Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Clinical trial NCT06804655 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06804655
Sponsor: University of Zurich
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Brain (Nervous System) Cancers Glioblastoma Glioma Ependymoma Medulloblastoma Meningioma Rare Primary Brain Tumors Rare CNS Primary Tumors

Start date: 2026-06-01
Primary completion: 2028-09-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.